13F HOLDINGS REPORT
Kinnevik AB (publ)
Quarter ended Q1 2025 · Filed April 28, 2025 · Accession 0001104659-25-040213
Total Value
$71.1M
Positions
1
Other Managers
1
Confidential Omitted
No
Holdings (1)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Recursion Pharmaceuticals, Inc. | RXRX | 13,434,171 | $71.1M | 100.00% |